[Latest] Global Amphibious Excavators Market Size/Share Worth USD 15 Billion by 2030 at a 11.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 24, 2023 01:30 ET
|
Custom Market Insights
Austin, TX, USA, July 24, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Amphibious Excavator Market Size, Trends and Insights By Type (Small amphibious...
Austrianova Secures Investment from Checkmate Capital
March 01, 2023 12:00 ET
|
SG Austria Pte Ltd
SINGAPORE, March 02, 2023 (GLOBE NEWSWIRE) -- SG Austria (“Austrianova”), a leading provider of cell biological products and services, today announced that Checkmate Capital Group (“Checkmate...
NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD
June 14, 2022 11:00 ET
|
NeuroSigma, Inc.
Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide Monarch eTNS Systems and funding for long-term follow-up ...
Lactiga Continues to Build a Substantial Global Biologics Patent Portfolio
July 20, 2021 09:00 ET
|
Lactiga, Inc
PRINCETON, N.J., July 20, 2021 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), a biotherapeutics company advancing anti-infective biologics to prevent mucosal infections in immunodeficient patients,...
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
November 02, 2020 10:00 ET
|
Checkmate Capital
PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing anti-infective biologics, is pleased to announce the completion of...
NeuroSigma Receives Bridge Financing from Checkmate Capital
September 21, 2020 11:00 ET
|
Checkmate Capital
To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. (“NeuroSigma”),...
TIAP announces New President and CEO
February 12, 2020 06:30 ET
|
Toronto Innovation Acceleration Partners
Toronto, Ontario, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of TIAP – Toronto Innovation Acceleration Partners (formerly MaRS Innovation) – is pleased to announce the appointment of...
NanoSphere Provides Update on United States Operations
December 09, 2019 09:00 ET
|
Nanosphere Health Sciences
Vancouver, Dec. 09, 2019 (GLOBE NEWSWIRE) -- NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“NanoSphere” or “the Company”) wishes to provide an update regarding its operations in the...
Toronto Innovation Acceleration Partners Announces Strategic Partnership with Amgen
September 09, 2019 07:00 ET
|
Toronto Innovation Acceleration Partners
Toronto, Ontario, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Toronto Innovation Acceleration Partners (TIAP – formerly MaRS Innovation), a leading member-based Canadian provider of venture builder expertise...
Kiwa Bio-Tech Products Group Corporation Reports its Operating Results for its Third Quarter ended September 30, 2016
November 22, 2016 09:00 ET
|
Kiwa Bio-Tech Products Group Corporation
CLAREMONT, Calif., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCQB:KWBT). On November 21, 2016, Kiwa Bio-Tech Products Group Corporation ("Kiwa" or the “Company”)...